Implementing, and adhering to, good infection control practices is critical to minimizing the impact of infectious diseases, including, but not limited to COVID-19. As a consultant pharmacist, I see additional opportunities for infection control practices that may not be as obvious as handwashing or PPE.
The Food and Drug Administration (FDA) recently cautioned against the use of hydroxychloroquine or chloroquine for the treatment of COVID-19 outside of a hospital setting or clinical trial.
The COVID-19 (coronavirus) pandemic we are all facing is an extraordinary situation that has greatly modified so many of the things we take for granted. There are many lessons already learned...and, of course, others still to come. One thing we know for certain is that some processes will be forever altered — and others will need to be improved. Although it may seem overwhelming right now, it’s prudent to start thinking about things that can be modified going forward. As a consultant pharmacist, below are five key items I suggest you think about now to better prepare yourself, and your facility, for a world post COVID-19.
With the White House announcing the Guidelines for Opening up America Again, Ambulatory Surgery Centers (ASCs) should be ready to go when your state provides specific guidance. Have you taken the appropriate steps to prepare?
Consultant pharmacists are medication management specialists who work in a variety of settings like ambulatory surgery centers (ASC), senior care facilities (e.g., nursing homes, assisted living facilities) and also by helping individual patients. These pharmacists provide expert advice on pharmaceutical services, patient safety, and drug therapy management.
In a three-part series, we will discuss how a consultant pharmacist can benefit each client and how you can find the right consultant pharmacist for your needs. This month, we’ll focus on how ASCs can enhance patient safety by using an expert consultant pharmacist. In the coming months, this series will also discuss how consultant pharmacists can have a dramatic impact on long-term care facilities and on individual patients’ lives.
Depending on your type of healthcare practice setting, you either have absolutely no free time, or very little to do during the current COVID-19 (coronavirus) pandemic. If you are one of the many healthcare professionals on the frontlines caring for those affected, your primary, and really, only focus, is to provide care and support for those who are ill, as well as yourself. Because of this shift in focus, there are some healthcare facilities and professionals who currently find themselves with extra time due to the sudden work reduction or work stoppage, including cancelation of elective surgeries. Don’t let this downtime go to waste…use it to prepare yourself, and your practice, to better serve your patients and enhance regulatory compliance. As a consultant pharmacist, I am always looking for ways to keep my facilities ahead of the curve: below are five ways to put your downtime to use and stay productive and be on the leading edge.
I want to share an update on what proactive steps OctariusRx is taking to keep our customers and our people safe while continuing to provide the exceptional services you rely on. These are unprecedented times and coronavirus (COVID-19) is having a dramatic impact on our lives and on many businesses. We want all our customers and patients to know we have a business continuity plan in place and will continue to provide all the services you are accustomed to.
Antibiotic stewardship is a global issue and it’s something we all must address. At the facility level, it’s not only a regulatory concern, it’s a patient safety issue. With the ongoing global spread of the Novel Coronavirus (COVID- 19), the issue of antibiotic stewardship (already a significant focus by the certification and accreditation bodies), has been pushed even further out into the spotlight. Beyond just being a survey challenge, antibiotic stewardship can have a profound impact on patient outcomes — not only today’s patients, but also future patients.